Related Experiment Video
Updated: Apr 2, 2026

Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
Microbial sensing through the non-canonical inflammasome modulates airway type 2 immunity
Olivier Bernard1, Sheyla Yamato1, Oluwaferanmi Bello1
1Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.
Introduction:
Airway epithelial cells serve as critical sensors of both microbes and allergens, orchestrating immune responses through damage-associated molecular patterns including IL-33. Common aeroallergens induce type 2 inflammation through protease activity and pore-forming mechanisms that trigger epithelial IL-33 secretion and MAPK signaling. While microbial pattern receptors such as caspase-4 (which detects intracellular LPS) similarly generate membrane pores via the non-canonical inflammasome, it remains unknown whether these receptors can engage the same downstream epithelial IL-33 release and MAPK activation pathways.
Methods:
Using human airway epithelial cell models, we examined caspase-4-dependent pyroptotic signaling downstream of intracellular LPS, including gasdermin D cleavage, IL-33 release, and MAPK-dependent transcriptional responses. We assessed the modulatory effect of protease allergen co-exposure on LPS-induced pyroptosis and interrogated the role of Orai1-mediated calcium signaling in vitro. In a mouse model of protease allergen challenge, we evaluated innate type 2 immune responses following genetic deletion of caspase-4 (formerly caspase-11). LPS preparations from multiple bacterial species were tested for capacity to engage the non-canonical inflammasome in epithelial cells, and publicly available human asthma datasets were analyzed for airway expression of caspase-4 and gasdermin D.
Results:
Intracellular LPS activated caspase-4-dependent pyroptotic signaling, resulting in gasdermin D cleavage, IL-33 release, and MAPK-dependent transcriptional responses. Protease allergen exposure enhanced LPS-induced pyroptotic responses through Orai1-mediated calcium signaling in vitro. Genetic deletion of caspase-4 attenuated innate type 2 immune responses in the mouse protease allergen challenge model. LPS preparations from different bacterial species demonstrated variable capacity to engage the non-canonical inflammasome. Analysis of human asthma datasets revealed increased airway expression of both caspase-4 and gasdermin D in asthmatic patients relative to healthy controls.
Discussion:
These findings identify the epithelial non-canonical inflammasome as a pathway capable of linking microbial pattern recognition to IL-33-dependent type 2 responses. This work establishes a mechanistic framework for understanding how bacterial sensing machinery may intersect with allergic inflammation during pathophysiological conditions, and suggests that caspase-4 signaling could represent a therapeutic target in asthma.
Insights
Airway epithelial cells sense microbes via caspase-4 (an inflammasome sensor), triggering IL-33 release and type 2 inflammation. This links bacterial sensing to allergic responses, suggesting caspase-4 as an asthma therapeutic target.
Area of Science:
- Immunology
- Cell Biology
- Respiratory Medicine
Background:
- Airway epithelial cells detect microbes and allergens, initiating immune responses via damage-associated molecular patterns like IL-33.
- Protease allergens trigger type 2 inflammation through epithelial IL-33 release and MAPK signaling.
- Microbial pattern receptors, such as caspase-4, can form membrane pores via the non-canonical inflammasome, but their link to epithelial IL-33 release and MAPK activation is unclear.
Purpose of the Study:
- To investigate caspase-4-dependent pyroptotic signaling downstream of intracellular LPS in airway epithelial cells.
- To determine if protease allergen co-exposure modulates LPS-induced pyroptosis and IL-33 release.
- To explore the role of caspase-4 in innate type 2 immune responses in a mouse model and its expression in human asthma.
Main Methods:
- Utilized human airway epithelial cell models to study caspase-4 activation, gasdermin D cleavage, IL-33 release, and MAPK responses to intracellular LPS.
- Assessed the impact of protease allergen co-exposure and Orai1-mediated calcium signaling on LPS-induced pyroptosis.
- Employed a mouse model with caspase-4 deletion to evaluate innate type 2 immune responses and analyzed human asthma datasets for caspase-4 and gasdermin D expression.
Main Results:
- Intracellular LPS triggered caspase-4-dependent pyroptosis, leading to gasdermin D cleavage, IL-33 release, and MAPK activation.
- Protease allergens enhanced LPS-induced pyroptosis via Orai1-mediated calcium signaling.
- Caspase-4 deletion attenuated type 2 immune responses in mice, and both caspase-4 and gasdermin D were upregulated in asthmatic patients.
Conclusions:
- The epithelial non-canonical inflammasome links microbial sensing to IL-33-dependent type 2 responses.
- This pathway provides a mechanistic link between bacterial sensing and allergic inflammation.
- Caspase-4 signaling emerges as a potential therapeutic target for asthma.
Related Concept Videos
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Inflammation

